Bafna Pharmaceuticals Ltd vs Medico Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 138.4 as of 04 May 11:38 . The P/E Ratio of Bafna Pharmaceuticals Ltd changed from 55.8 on March 2021 to 42.6 on March 2025 . This represents a CAGR of -5.26% over 5 yearsThe P/E Ratio of Medico Remedies Ltd changed from 16 on March 2021 to 42.7 on March 2025 . This represents a CAGR of 21.69% over 5 years The Market Cap of Bafna Pharmaceuticals Ltd changed from ₹ 324.8 crore on March 2021 to ₹ 177.42 crore on March 2025 . This represents a CAGR of -11.39% over 5 yearsThe Market Cap of Medico Remedies Ltd changed from ₹ 41.49 crore on March 2021 to ₹ 432.35 crore on March 2025 . This represents a CAGR of 59.80% over 5 years The revenue of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 39.51 crore as compare to the Sep '25 revenue of ₹ 36.65 crore. This represent the growth of 7.8% The revenue of Medico Remedies Ltd for the Dec '25 is ₹ 59.36 crore as compare to the Sep '25 revenue of ₹ 54.36 crore. This represent the growth of 9.2% The ebitda of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 4.27 crore as compare to the Sep '25 ebitda of ₹ 5.46 crore. This represent the decline of -21.79% The ebitda of Medico Remedies Ltd for the Dec '25 is ₹ 5.01 crore as compare to the Sep '25 ebitda of ₹ 4.44 crore. This represent the growth of 12.84% The net profit of Bafna Pharmaceuticals Ltd changed from ₹ -0.72 crore to ₹ 1.84 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Medico Remedies Ltd changed from ₹ 1.58 crore to ₹ 2.87 crore over 7 quarters. This represents a CAGR of 40.65% The Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Medico Remedies Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and is engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non Betalactum products.
The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

About Medico Remedies Ltd

Medico Remedies Limited was incorporated as a Private Limited Company as 'Medico Remedies Private Limited' on March 18, 1994.
The status was changed to a Public Company and the name of the Company was changed to Medico Remedies Limited on March 6, 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements.
Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.

FAQs for the comparison of Bafna Pharmaceuticals Ltd and Medico Remedies Ltd

Which company has a larger market capitalization, Bafna Pharmaceuticals Ltd or Medico Remedies Ltd?

Market cap of Bafna Pharmaceuticals Ltd is 321 Cr while Market cap of Medico Remedies Ltd is 352 Cr

What are the key factors driving the stock performance of Bafna Pharmaceuticals Ltd and Medico Remedies Ltd?

The stock performance of Bafna Pharmaceuticals Ltd and Medico Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bafna Pharmaceuticals Ltd and Medico Remedies Ltd?

As of May 4, 2026, the Bafna Pharmaceuticals Ltd stock price is INR ₹135.7. On the other hand, Medico Remedies Ltd stock price is INR ₹42.5.

How do dividend payouts of Bafna Pharmaceuticals Ltd and Medico Remedies Ltd compare?

To compare the dividend payouts of Bafna Pharmaceuticals Ltd and Medico Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.